128 related articles for article (PubMed ID: 33156188)
1. Low Human Immunodeficiency Virus (HIV) Testing Rates and No HIV Preexposure Prophylaxis Prescribed Among Female Patients Diagnosed With a Sexually Transmitted Infection, 2017-2018.
Henny KD; Huang YA; Hoover KW
Obstet Gynecol; 2020 Dec; 136(6):1083-1085. PubMed ID: 33156188
[No Abstract] [Full Text] [Related]
2. Population and Individual-Level Effects of Human Immunodeficiency Virus Preexposure Prophylaxis on Sexually Transmitted Infection Epidemics Among Men Who Have Sex With Men.
Grey JA; Torrone EA; Sullivan PS; Weiss KM; Aral SO
Sex Transm Dis; 2019 Dec; 46(12):759-761. PubMed ID: 31764765
[No Abstract] [Full Text] [Related]
3. Human Immunodeficiency Virus/Sexually Transmitted Infection Counseling and Testing Services Received by Gay and Bisexual Men Using Preexposure Prophylaxis at Their Last PrEP Care Visit.
Parsons JT; John SA; Whitfield THF; Cienfuegos-Szalay J; Grov C
Sex Transm Dis; 2018 Dec; 45(12):798-802. PubMed ID: 30422969
[TBL] [Abstract][Full Text] [Related]
4. Availability of Sexually Transmitted Disease and HIV Clinical Services: Ending the HIV Epidemic Versus Non-Ending the HIV Epidemic Jurisdictions, 2018.
Leichliter JS; Cuffe KM; Kelley KR; Gift TL
Sex Transm Dis; 2022 Jan; 49(1):e13-e16. PubMed ID: 34030153
[TBL] [Abstract][Full Text] [Related]
5. Sexually Transmitted Infections in Youth With Controlled and Uncontrolled Human Immunodeficiency Virus Infection.
Camacho-Gonzalez AF; Chernoff MC; Williams PL; Chahroudi A; Oleske JM; Traite S; Chakraborty R; Purswani MU; Abzug MJ;
J Pediatric Infect Dis Soc; 2017 Sep; 6(3):e22-e29. PubMed ID: 27440505
[TBL] [Abstract][Full Text] [Related]
6. Nonoccupational Postexposure Prophylaxis and Preexposure Prophylaxis for Human Immunodeficiency Virus Prevention in Adolescents and Young Adults.
Straub DM; Mullins TLK
Adv Pediatr; 2019 Aug; 66():245-261. PubMed ID: 31230697
[No Abstract] [Full Text] [Related]
7. Low HIV testing rates among US women who report anal sex and other HIV sexual risk behaviors, 2011-2015.
Evans ME; Tao G; Porter SE; Gray SC; Huang YA; Hoover KW
Am J Obstet Gynecol; 2018 Oct; 219(4):383.e1-383.e7. PubMed ID: 30144401
[TBL] [Abstract][Full Text] [Related]
8. Rates of New Human Immunodeficiency Virus (HIV) Diagnoses After Reported Sexually Transmitted Infection in Women in Louisiana, 2000-2015: Implications for HIV Prevention.
Newman DR; Rahman MM; Brantley A; Peterman TA
Clin Infect Dis; 2020 Mar; 70(6):1115-1120. PubMed ID: 30976788
[TBL] [Abstract][Full Text] [Related]
9. Association of HIV Preexposure Prophylaxis With Incidence of Sexually Transmitted Infections Among Individuals at High Risk of HIV Infection.
Traeger MW; Cornelisse VJ; Asselin J; Price B; Roth NJ; Willcox J; Tee BK; Fairley CK; Chang CC; Armishaw J; Vujovic O; Penn M; Cundill P; Forgan-Smith G; Gall J; Pickett C; Lal L; Mak A; Spelman TD; Nguyen L; Murphy DA; Ryan KE; El-Hayek C; West M; Ruth S; Batrouney C; Lockwood JT; Hoy JF; Hellard ME; Stoové MA; Wright EJ;
JAMA; 2019 Apr; 321(14):1380-1390. PubMed ID: 30964528
[TBL] [Abstract][Full Text] [Related]
10. Patient Disengagement From an HIV Preexposure Prophylaxis Program in a Sexually Transmitted Disease Clinic.
Dombrowski JC; Golden MR; Barbee LA; Khosropour CM
Sex Transm Dis; 2018 Sep; 45(9):e62-e64. PubMed ID: 29485544
[TBL] [Abstract][Full Text] [Related]
11. Prior Sexually Transmitted Infection and Human Immunodeficiency Virus Risk Perception in a Diverse At-Risk Population of Men Who Have Sex with Men and Transgender Individuals.
Resnick D; Morales K; Gross R; Petsis D; Fiore D; Davis-Vogel A; Metzger D; Frank I; Wood S
AIDS Patient Care STDS; 2021 Jan; 35(1):15-22. PubMed ID: 33400589
[TBL] [Abstract][Full Text] [Related]
12. Vital Signs: Status of Human Immunodeficiency Virus Testing, Viral Suppression, and HIV Preexposure Prophylaxis - United States, 2013-2018.
Harris NS; Johnson AS; Huang YA; Kern D; Fulton P; Smith DK; Valleroy LA; Hall HI
MMWR Morb Mortal Wkly Rep; 2019 Dec; 68(48):1117-1123. PubMed ID: 31805031
[TBL] [Abstract][Full Text] [Related]
13. Human Immunodeficiency Virus Pre-exposure Prophylaxis and Increased Incidence of Sexually Transmitted Infections in the United States.
Serpa JA; Huynh GN; Nickell JB; Miao H
Clin Infect Dis; 2020 Apr; 70(9):1884-1890. PubMed ID: 31284300
[TBL] [Abstract][Full Text] [Related]
14. Sexually Transmitted Infection Testing Among Unstably Housed, Sexually Active Persons With Human Immunodeficiency Virus in the United States, 2018-2019.
Marcus R; Tie Y; Dasgupta S; Crim SM; Beer L; Williams SP; Weiser J
Sex Transm Dis; 2022 Dec; 49(12):841-843. PubMed ID: 35858476
[TBL] [Abstract][Full Text] [Related]
15. Risk factors associated with human immunodeficiency virus (HIV) infection among attendees of public sexually transmitted infection clinics in Hong Kong: implications for HIV prevention.
Lee PM; Ho KM
Hong Kong Med J; 2008 Aug; 14(4):259-66. PubMed ID: 18685157
[TBL] [Abstract][Full Text] [Related]
16. Low HIV incidence among women following sexually transmitted infection does not support national pre-exposure prophylaxis recommendations.
Berzkalns AE; Barbee LA; Dombrowski JC; Golden MR
AIDS; 2020 Jul; 34(9):1429-1431. PubMed ID: 32590439
[TBL] [Abstract][Full Text] [Related]
17. No New HIV Infections With Increasing Use of HIV Preexposure Prophylaxis in a Clinical Practice Setting.
Volk JE; Marcus JL; Phengrasamy T; Blechinger D; Nguyen DP; Follansbee S; Hare CB
Clin Infect Dis; 2015 Nov; 61(10):1601-3. PubMed ID: 26334052
[TBL] [Abstract][Full Text] [Related]
18. Sexually transmitted infections in the preexposure prophylaxis era.
Meyer L; Schim van der Loeff MF
AIDS; 2024 Jun; 38(7):1085-1086. PubMed ID: 38691051
[No Abstract] [Full Text] [Related]
19. Impact of Providing Preexposure Prophylaxis for Human Immunodeficiency Virus at Clinics for Sexually Transmitted Infections in Baltimore City: An Agent-based Model.
Kasaie P; Berry SA; Shah MS; Rosenberg ES; Hoover KW; Gift TL; Chesson H; Pennington J; German D; Flynn CP; Beyrer C; Dowdy DW
Sex Transm Dis; 2018 Dec; 45(12):791-797. PubMed ID: 29944642
[TBL] [Abstract][Full Text] [Related]
20. Legal Barriers to Adolescent Participation in Research About HIV and Other Sexually Transmitted Infections.
Moore QL; Paul ME; McGuire AL; Majumder MA
Am J Public Health; 2016 Jan; 106(1):40-4. PubMed ID: 26562103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
